Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

London's blue-chip index jumped to a record high on Thursday, lifted by shares of AstraZeneca after upbeat results and ahead ...

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

By Pushkala Aripaka and Maggie Fick (Reuters) -AstraZeneca shares rose on Thursday after the drugmaker said it could face a ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

AstraZeneca has ended development of its oral factor D inhibitor vemircopan, triggering a $753 million impairment charge as ...

Drugmaker AstraZeneca has warned it could face a fine in China over possible unpaid import taxes, as it revealed strong sales ...

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...

AstraZeneca said the taxes related to two cancer drugs, Imfinzi and Imjudo, and that it was continuing to co-operate with ...

UBS analyst Matthew Weston maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of £115.00. The ...

Reports Q4 reported EPS 97c vs. 62c last year. Reports Q4 revenue $14.89B, consensus $14.28B. Pascal Soriot, CEO, AstraZeneca (AZN), ...